Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of exenatide for Parkinson's disease
ISRCTN14552789Phase 3Completed
- Sponsor
- University College London
- Start
- Jan 2020
- Modality
- Peptides
01
Overview
Phase 3, randomised, double-blind trial in Parkinson's disease (PD) comparing Exenatide with Placebo (2 arms). Started Jan 2020; status: completed.
02
Drugs
exenatide
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on ISRCTN14552789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN14552789.